Enovix is trading 5.05% lower at $2.73, with no clear company-specific announcement explaining the September 28 decline.
- The company’s latest release listings show a most recent release dated September 1.
- Broader risk-off pressure may be contributing, with geopolitical and oil-price concerns and elevated Treasury yields weighing on markets. Major-index declines are less than 0.5%, and the available evidence does not establish a direct market-wide cause.